Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism VEGFR2 antagonists(Vascular endothelial growth factor receptor 2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC28H43N7O9 |
InChIKeyCTHOVYCXWNPTSN-CMOCDZPBSA-N |
CAS Registry2412172-33-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Retinal Degeneration | Phase 1 | KR | 30 Jan 2022 |